Login to Your Account

Washington Roundup

FDA Approves REMS for Most Powerful Opioids

By Mari Serebrov
Washington Editor

Wednesday, August 8, 2012

In the latest salvo against the growing problem of prescription drug abuse and misuse, the FDA approved a classwide risk evaluation and mitigation strategy (REMS) for extended-release and long-acting opioid drugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription